Indian pharmaceutical company Cipla on Friday posted a 43.8% year-on-year drop in its net profit at ₹365 crore in the quarter ended June. The net sales for the quarter were ₹3,500 crore which is 6.9 % less than the corresponding period of last fiscal. Further, Cipla's CEO Subhanu Saxena has resigned citing emerging "family priorities”. 